Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
22-Oct-15 China's recently-announced reform of county-level hospitals is seriously underfunded, according to experts. Fudan University professor Hu Shanlian said "Now that hospitals are no longer allowed to mark up drugs, the drop in their revenue is huge". Hospitals are expected to raise service fees to compensate, however this may also raise expenses for patients, defeating the purpose of the reforms. [image: South China Morning Post]Read More
21-Oct-15 GlaxoSmithKline's chief executive is joining a new panel to promote trade between Britain and China, just over a year after the drugmaker was handed a record fine of nearly USD500 mn (GBP323 mn ) for bribing Chinese doctors. The group has since been rebuilding its position in China. [image: Reuters / Luke Macgregor]Read More
20-Oct-15 AstraZeneca announced a new state-of-the-art manufacturing and packaging facility in Kaluga, Russia, dedicated to the local supply of innovative medicines. In 2011 AstraZeneca was one of the first multinational pharmaceutical companies to announce plans to invest in the construction of a dedicated manufacturing facility in Russia. Four years on, the Company has invested USD224m. [image: AstraZeneca]Read More
20-Oct-15 Associate Professor James Yip, the chief medical information officer at National University Health System (NUHS), started the telehealth programme there last February. Since then, some 1,300 patients with hypertension, diabetes and heart failure have benefited from being monitored online. [image: ST / Alicia Chan]Read More
20-Oct-15 By understanding how China’s demographic profile will change we can see the opportunities that may emerge in future years. Education is important as it influences not only the productivity of a worker but it also influences many aspects of society such as reducing the propensity to have more than one child, lifestyle choice and health. The challenge now is to reduce the differential between provinces. [image: Global Demographics]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Get in touch to discuss your growth markets research and advisory needs: